DK1435231T3 - Ikke-pegylerede længe cirkulerende liposomer - Google Patents

Ikke-pegylerede længe cirkulerende liposomer

Info

Publication number
DK1435231T3
DK1435231T3 DK03258252.0T DK03258252T DK1435231T3 DK 1435231 T3 DK1435231 T3 DK 1435231T3 DK 03258252 T DK03258252 T DK 03258252T DK 1435231 T3 DK1435231 T3 DK 1435231T3
Authority
DK
Denmark
Prior art keywords
liposomes
phospholipid
sucrose
ammonium sulphate
hydration
Prior art date
Application number
DK03258252.0T
Other languages
English (en)
Inventor
Gautam Vinod Daftary
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Original Assignee
Zydus Bsv Pharma Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zydus Bsv Pharma Private Ltd filed Critical Zydus Bsv Pharma Private Ltd
Application granted granted Critical
Publication of DK1435231T3 publication Critical patent/DK1435231T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes
    • A61K9/1278Post-loading, e.g. by ion or pH gradient
DK03258252.0T 2002-12-31 2003-12-31 Ikke-pegylerede længe cirkulerende liposomer DK1435231T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1101MU2002 2002-12-31

Publications (1)

Publication Number Publication Date
DK1435231T3 true DK1435231T3 (da) 2010-04-26

Family

ID=32500467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03258252.0T DK1435231T3 (da) 2002-12-31 2003-12-31 Ikke-pegylerede længe cirkulerende liposomer

Country Status (19)

Country Link
EP (1) EP1435231B8 (da)
JP (1) JP5355842B2 (da)
KR (2) KR101133084B1 (da)
CN (1) CN1756533B (da)
AT (1) ATE453381T1 (da)
AU (1) AU2003303368B2 (da)
BR (1) BR0317882A (da)
CA (1) CA2511464C (da)
DE (1) DE60330745D1 (da)
DK (1) DK1435231T3 (da)
EA (1) EA008930B1 (da)
ES (1) ES2337563T3 (da)
HK (1) HK1089946A1 (da)
IL (1) IL169364A (da)
MX (1) MXPA05007102A (da)
NZ (1) NZ540778A (da)
PT (1) PT1435231E (da)
WO (1) WO2004058140A2 (da)
ZA (1) ZA200504850B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101743020A (zh) * 2007-05-16 2010-06-16 Ktb肿瘤研究有限责任公司 低粘度蒽环制剂
NZ595212A (en) * 2009-03-30 2014-02-28 Eisai R&D Man Co Ltd Liposome composition
EP2415464B1 (en) 2009-03-30 2017-05-10 Eisai R&D Management Co., Ltd. Method for producing liposome composition
WO2012118376A1 (en) * 2011-03-01 2012-09-07 To-Bbb Holding B.V. Advanced active liposomal loading of poorly water-soluble substances
MX2019003317A (es) * 2016-09-27 2019-08-05 Vertex Pharma Metodo para tratar cancer usando una combinacion de agentes que dañan adn e inhibidores de proteina cinasa dependiente de adn (adn-pk).
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
CN116570775A (zh) * 2023-05-16 2023-08-11 万瑞飞鸿(北京)医疗器材有限公司 一种药物涂层、血管支架及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
EP0153955A1 (en) * 1983-09-06 1985-09-11 Health Research, Inc. Liposome delivery method for decreasing the toxicity of an antitumor drug
CA1270198A (en) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation of antineoplastic agents in liposomes
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
JPH0720857B2 (ja) 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US6132763A (en) 1988-10-20 2000-10-17 Polymasc Pharmaceuticals Plc Liposomes
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
WO1998007409A1 (en) * 1996-08-23 1998-02-26 Sequus Pharmaceuticals, Inc. Liposomes containing a cisplatin compound
EP1121102B1 (en) * 1998-09-16 2003-04-23 Alza Corporation Liposome-entrapped topoisomerase inhibitors
KR20000061075A (ko) * 1999-03-23 2000-10-16 린 중친 리포솜의 응집을 방지하기 위한 방법 및 조성물
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes

Also Published As

Publication number Publication date
KR101171045B1 (ko) 2012-08-03
EP1435231A1 (en) 2004-07-07
AU2003303368B2 (en) 2010-06-17
JP2006513189A (ja) 2006-04-20
DE60330745D1 (de) 2010-02-11
NZ540778A (en) 2008-04-30
IL169364A0 (en) 2007-07-04
HK1089946A1 (en) 2006-12-15
EA200500850A1 (ru) 2006-02-24
EP1435231B1 (en) 2009-12-30
KR101133084B1 (ko) 2012-04-04
IL169364A (en) 2012-05-31
KR20110075051A (ko) 2011-07-05
CN1756533B (zh) 2010-06-16
CN1756533A (zh) 2006-04-05
WO2004058140A2 (en) 2004-07-15
AU2003303368A1 (en) 2004-07-22
ES2337563T3 (es) 2010-04-27
WO2004058140A3 (en) 2004-10-28
EA008930B1 (ru) 2007-08-31
BR0317882A (pt) 2005-12-13
ATE453381T1 (de) 2010-01-15
CA2511464C (en) 2011-08-23
CA2511464A1 (en) 2004-07-15
MXPA05007102A (es) 2005-08-26
KR20050088233A (ko) 2005-09-02
WO2004058140B1 (en) 2004-12-16
PT1435231E (pt) 2010-04-08
EP1435231B8 (en) 2010-03-03
JP5355842B2 (ja) 2013-11-27
ZA200504850B (en) 2006-08-30

Similar Documents

Publication Publication Date Title
HK1089946A1 (en) Non-pegylated long-circulating liposomes
AR028504A2 (es) Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial
AR002262A1 (es) Composicion y metodo para el tratamiento de enfermedades fungales de las unas y un vendaje adaptado para la administracion topica de medicacion a lasunas.
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
EA200300457A1 (ru) Кристаллический моногидрат, способ его получения и его применение для получения лекарственного средства
IL168279A (en) Use of liposomal and aminoglycoside composition to prepare a drug for the treatment or improvement of infection
AU4010701A (en) Methods and kits for locally administering an active agent to an interstitial space of a host
ES2195220T3 (es) Acidos sulfonilaminocarboxilicos.
FI962948A (fi) Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi
RU94040170A (ru) Изохинолины
BR0117106A (pt) Compostos de lipossoma de microesfera de gás
CO5251448A1 (es) Soluciones que contienen epinastina
ATE248187T1 (de) Echinocandin-kohlenhydrate-komplexe
RU2210573C2 (ru) Углеводные производные
RU99124771A (ru) Применение альфа-метил-п-тирозина для ингибирования продуцирования меланина в меланоцитах радужной оболочки
LV5765A4 (lv) (S)-(-)-1-propil-2',6'-pipekoloksilidida hidrohlorida monohidrats ta iegusanas metode un to satuross farmaceitisks preparats
AR006345A1 (es) Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion.
BR9917389A (pt) Formulações tópicas compreendendo agentes de penetração na pele e o uso das mesmas
CA2241825A1 (en) New monofunctionalized edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
RU2003104017A (ru) Ингибиторы тромбина, содержащие аминоизохинолиновую группу
ATE288762T1 (de) Kardiopflegische lösung
CO5180574A1 (es) Micofenolato mofetil en asociacion con peg-inf-a
BR0110989A (pt) Derivados de 2-aminotetralina opticamente ativos, os processos para a preparação deles e uso terapêutico de composições farmacêuticas que os contêm
JPH0251517U (da)
DE3851842T2 (de) Wässrige bereitung von liposomenzusammensetzungen.